136 related articles for article (PubMed ID: 23416124)
1. FMD virus isolates: the candidate strains for polyvalent vaccine development in Ethiopia.
Ayelet G; Soressa M; Sisay T; Belay A; Gelaye E; Jembere S; Skjerve E; Asmare K
Acta Trop; 2013 Jun; 126(3):244-8. PubMed ID: 23416124
[TBL] [Abstract][Full Text] [Related]
2. Vaccine matching and antigenic variability of foot-and-mouth disease virus serotypes O and A from 2018 Ethiopian isolates.
Tesfaye Y; Khan F; Gelaye E
Int Microbiol; 2022 Jan; 25(1):47-59. PubMed ID: 34224048
[TBL] [Abstract][Full Text] [Related]
3. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
Xu W; Zhang Z; Nfon C; Yang M
Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
[TBL] [Abstract][Full Text] [Related]
4. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
5. Isolation, molecular characterization and sero-prevalence study of foot-and-mouth disease virus circulating in central Ethiopia.
Sulayeman M; Dawo F; Mammo B; Gizaw D; Shegu D
BMC Vet Res; 2018 Mar; 14(1):110. PubMed ID: 29587741
[TBL] [Abstract][Full Text] [Related]
6. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
[TBL] [Abstract][Full Text] [Related]
7. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
[TBL] [Abstract][Full Text] [Related]
8. A vaccine-matching assessment of different genetic variants of serotype O foot-and-mouth disease virus isolated in Ethiopia between 2011 and 2014.
Tesfaye Y; Khan F; Yami M; Wadsworth J; Knowles NJ; King DP; Gelaye E
Arch Virol; 2020 Aug; 165(8):1749-1757. PubMed ID: 32435857
[TBL] [Abstract][Full Text] [Related]
9. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
[TBL] [Abstract][Full Text] [Related]
11. Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.
Maradei E; Perez Beascoechea C; Malirat V; Salgado G; Seki C; Pedemonte A; Bonastre P; D'Aloia R; La Torre JL; Mattion N; Rodríguez Toledo J; Bergmann IE
Vaccine; 2011 Oct; 29(46):8230-40. PubMed ID: 21911020
[TBL] [Abstract][Full Text] [Related]
12. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
[TBL] [Abstract][Full Text] [Related]
13. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India.
Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK
Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900
[TBL] [Abstract][Full Text] [Related]
14. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.
Mattion N; Goris N; Willems T; Robiolo B; Maradei E; Beascoechea CP; Perez A; Smitsaart E; Fondevila N; Palma E; De Clercq K; La Torre J
Vaccine; 2009 Jan; 27(5):741-7. PubMed ID: 19041355
[TBL] [Abstract][Full Text] [Related]
15. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
[TBL] [Abstract][Full Text] [Related]
16. Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.
Kotecha A; Perez-Martin E; Harvey Y; Zhang F; Ilca SL; Fry EE; Jackson B; Maree F; Scott K; Hecksel CW; Harmsen MM; Mioulet V; Wood B; Juleff N; Stuart DI; Charleston B; Seago J
Sci Rep; 2018 Sep; 8(1):13654. PubMed ID: 30209254
[TBL] [Abstract][Full Text] [Related]
17. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a high quality O
Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
[TBL] [Abstract][Full Text] [Related]
19. Humoral Immune Response in Calves Vaccinated with Monovalent Vaccines or a Trivalent Combination Thereof and Matching of These Vaccines to the Selected Circulating Foot-and-Mouth Disease Viruses in Ethiopia.
Woldemariyam FT; Negessu D; Bilata T; Muluneh A; Gebreweld DS; Ebisa IT; Paeshuyse J
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631920
[TBL] [Abstract][Full Text] [Related]
20. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.
Seki C; Robiolo B; Periolo O; Iglesias M; D'Antuono A; Maradei E; Barros V; La Torre J; Mattion N
Vet Microbiol; 2009 Jan; 133(3):239-51. PubMed ID: 18774662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
